Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07693621

Intraperitoneal Dexmedetomidine Versus Magnesium as Adjuvants to Bupivacaine in Laparoscopic Cholecystectomy

Conditions: Dexmedetomidine, Magnesium Sulfate, Laparoscopic Cholecystectomy

Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Phase: NA
Enrollment: 80
Sponsor: Alexandria University

Location: Alexandria University Alexandria

Summary

Although both dexmedetomidine and magnesium sulphate have been individually evaluated as adjuvants to local anesthetics, direct comparisons between the two agents in intraperitoneal instillation during laparoscopic cholecystectomy remain limited. Understanding their relative efficacy and safety could provide valuable guidance for optimizing perioperative analgesia in these patients.

Eligibility Criteria

Inclusion Criteria: * Patients aged 18-60 years * ASA physical status I-II * scheduled for elective laparoscopic cholecystectomy under general anesthesia. Exclusion Criteria: * Known hypersensitivity to study drugs * history of cardiac arrhythmias or conduction abnormalities * severe hepatic/renal impairment * chronic opioid or analgesic use * pregnancy * conversion to open surgery * drain insertion.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07693621). StuddyBuddy aggregates publicly available trial information.